## Background: Angiogenesis is essential for tumor growth and metastasis. vascular endothelial growth factor (vegf) is the most potent angiogenic factor identified to date. the authors investigated the correlation between the levels of serum vegf (s-vegf) in patients with nasopharyngeal carcinoma (
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy
โ Scribed by Dr. P. A. D'Amore; R. H. Brown Jr; P-T. Ku; E. P. Hoffman; H. Watanabe; K. Arahata; T. Ishihara; J. Folkman
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 440 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai
## BACKGROUND. Both benign and malignant growth of the prostate depend on the induction of a microvasculature. Basic fibroblast growth factor (bFGF), a potent angiogenic factor, is thought to play an important role in this process. METHODS. bFGF expression in prostatic carcinoma was assessed by EL
## Background: Transforming growth factor-beta1 (tgf-beta1) acts as a potent inhibitor of cell growth and tumor progression but loss of this negative regulation can contribute to tumor development. some studies have reported an association between disease progression and tgf-beta1 expression in pat